首页> 美国卫生研究院文献>GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW >The micropolyurethane foam-coated Diagon/Gel®4Two implant in aesthetic and reconstructive breast surgery – 3-year results of an ongoing study
【2h】

The micropolyurethane foam-coated Diagon/Gel®4Two implant in aesthetic and reconstructive breast surgery – 3-year results of an ongoing study

机译:微聚氨酯泡沫涂层的Diagon /Gel®4Two植入物用于美学和重建性乳房手术–一项正在进行的研究的3年结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Breast implants are worldwide in use since 1962. Initially there were some problems with capsular contracture and the palpability of the rim of the implant. In 1968 this led to the introduction of the micropolyurethane foam-coating and then in 1970 to the first micropolyurethane foam-coated implant by F.A. Ashley. As a result of additional technical refinements in manufacturing this new implant design significantly reduced complications i.e. capsular contracture and implant rotation. >Methods: This study reports a single surgeon’s experience with aesthetic and reconstructive breast surgery, in primary and secondary cases with the sole use of micropolyurethane foam-coated Diagon/gel®4Two implants, partly in combination with the additional use of synthetic meshes, acellular dermal matrices and lipofilling. The trial is a prospective, single center cohort study designed to demonstrate the safety and effectiveness of the new implant design in primary and secondary aesthetic and reconstructive breast surgery. The reported data provide an interim report of the implantations performed from November 2010 to December 2013.>Results: 90 patients were admitted to the study with 152 implants. The majority of the implants (n=95, 62.5%) were used in reoperative cases for either oncological (n=52, 34.2%) or aesthetic reasons (n=43, 28.3%). The median age of the study cohort was 45 years; the median body mass index was 21; the median observation time is 41 months. There was a very low complication rate, both short term within 6 weeks after the implantation of the silicone gel implant and in the follow up in November 2015. There were no serious complications needing explantation, no capsular fibrosis or implant rotation or rupture so far. There were only 4 minor complications (1.97%). There was 1 local recurrence 4 years after skin and nipple sparing mastectomy.>Conclusion: The micropolyurethane foam-coated Diagon/gel®4Two implant is a very reliable silicone gel implant filled with two high cross-linked, cohesive and form stable gels. The study demonstrated a very high safety profile of the 4Two implant and its effectiveness in both primary and secondary reoperative aesthetic, oncological and reconstructive breast surgery. The study is ongoing, a longer follow-up will be needed to consolidate the data.
机译:>背景:自1962年以来,全世界都在使用乳房植入物。最初,包膜挛缩和植入物边缘的可触性存在一些问题。 1968年,这导致了微聚氨酯泡沫涂层的引入,然后在1970年由F.A. Ashley引入了第一款微聚氨酯泡沫涂层的植入物。由于在制造过程中进行了其他技术改进,这种新的植入物设计显着减少了并发症,即囊膜挛缩和植入物旋转。 >方法:该研究报告了一位外科医生在初次和二次病例中仅使用微聚氨酯泡沫涂层的Diagon / gel ® 4两种植入物进行美学和重建性乳房手术的经验。 ,部分与合成网,无细胞真皮基质和脂肪填充的其他用途结合使用。该试验是一项前瞻性,单中心队列研究,旨在证明新植入物设计在原发性和继发性美学和重建性乳房手术中的安全性和有效性。报告的数据提供了从2010年11月至2013年12月进行的植入的中期报告。>结果:该研究收治了90例患者,其中包括152个植入物。出于肿瘤原因(n = 52,34.2%)或出于美学原因(n = 43,28.3%),大多数植入物(n = 95,62.5%)用于手术病例。研究队列的中位年龄为45岁;中位数体重指数为21;中位观察时间为41个月。硅酮凝胶植入物植入后的6周内和2015年11月的随访中,并发症发生率都很低。到目前为止,没有严重的并发症需要植入,也没有囊膜纤维化或植入物旋转或破裂。仅发生4例轻微并发症(1.97%)。保留皮肤和乳头的乳房切除术后4年发生1次局部复发。>结论:微聚氨酯泡沫涂层的Diagon / gel ® 4Two植入物是一种非常可靠的硅凝胶植入物,其中充满两种高交联,内聚并形成稳定的凝胶。这项研究表明4Two植入物具有很高的安全性,并且在初次和二次手术的美学,肿瘤学和重建性乳房手术中均有效。研究正在进行中,将需要更长的随访时间来合并数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号